U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower June 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CF Industries, Kimberly-Clark and Welltower, on Wednesday.
HIGHLIGHTS
* Applied Materials Inc AMAT.O: Citigroup raises target price to $710 from $550 |
* CF Industries Holdings CF.N: HSBC cuts target price to $121 from $130 |
* Huntsman Corp HUN.N: Mizuho raises to neutral from underperform |
* Kimberly-Clark KMB.O: Piper Sandler raises target price to $121 from $115 |
* Welltower Inc WELL.N: Raymond James resumes coverage with outperform rating |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* American Homes 4 Rent AMH.N: Mizuho raises target price to $35 from $29 |
* Applied Materials Inc AMAT.O: Citigroup raises target price to $710 from $550 |
* Arrowhead Pharmaceuticals ARWR.O: Leerink Partners raises target price to $72 from $61 |
* Assurant Inc AIZ.N: Truist Securities raises target price to $310 from $290 |
* Brightview Holdings BV.N: Oppenheimer initiates coverage with outperform rating; PT $17 |
* Caretrust REIT CTRE.N: Raymond James resumes coverage with outperform rating; PT $43 |
* Carter'S, Inc. CRI.N: Wells Fargo raises target price to $42 from $30 |
* Carter'S, Inc. CRI.N: Wells Fargo raises to equal weight from underweight |
* Caterpillar Inc CAT.N: JP Morgan raises target price to $1,165 from $1,125 |
* CF Industries Holdings CF.N: HSBC cuts target price to $121 from $130 |
* Chiron Real Estate XRN.N: Raymond James initiates coverage with market perform rating |
* Cinemark Holdings Inc CNK.N: Benchmark raises target price to $37 from $35 |
* Cognizant CTSH.O: Berenberg cuts to hold from buy; cuts PT to $59 from $81 |
* Constellation Brands Inc STZ.N: UBS cuts target price to $175 from $186 |
* Corbus Pharmaceuticals Holdings CRBP.O: Oppenheimer cuts target price to $52 from $54 |
* Cummins Inc. CMI.N: Wells Fargo raises target price to $874 from $794 |
* Datadog Inc (Pre-Reincorporation) DDOG.O: Citigroup raises PT to $270 from $218 |
* Fedex Corporation FDX.N: Wells Fargo cuts target price to $425 from $450 |
* Figma Inc FIG.N: Citigroup initiates coverage with buy rating; price target $36 |
* Glaukos Corp GKOS.N: Needham raises target price to $150 from $136 |
* Guardant Health Inc GH.O: Jefferies raises target price to $150 from $130 |
* Guardian Pharmacy Services GRDN.N: BofA Global Research raises PO to $47.00 from $42.00 |
* Guardian Pharmacy Services Inc GRDN.N: Truist Securities raises PT to $47 from $43 |
* H.B. Fuller Company FUL.N: UBS raises target price to $71 from $63 |
* Healthcare Realty Trust HR.N: Raymond James resumes coverage with outperform rating |
* Healthcare Realty Trust HR.N: Raymond James resumes coverage with target price $24 |
* Healthpeak Properties DOC.N: Raymond James resumes coverage with market perform rating |
* Hemab Therapeutics Holdings COAG.O: H.C. Wainwright initiates coverage with PT $40 |
* Hemab Therapeutics Holdings COAG.O: H.C. Wainwright initiates coverage with buy rating |
* Host Hotels and Resorts, Inc HST.O: Argus Research raises target price to $27 from $20 |
* Humacyte Inc HUMA.O: TD Cowen cuts target price to $1.25 from $1.5 |
* Huntsman Corp HUN.N: Mizuho raises target price to $14 from $10 |
* Huntsman Corp HUN.N: Mizuho raises to neutral from underperform |
* Immutep Ltd IMMP.O: Maxim Group raises to buy from hold |
* Incyte INCY.O: Jefferies raises target price to $100 from $94 |
* International CRL.N: Morgan Stanley raises target price to $220 from $185 |
* Invitation Homes Inc INVH.N: Mizuho raises target price to $31 from $26 |
* Ionis Pharmaceuticals Inc IONS.O: Leerink Partners raises PT to $122 from $114 |
* Iqvia Holdings Inc IQV.N: Morgan Stanley cuts target price to $200 from $225 |
* Iqvia Holdings Inc IQV.N: Morgan Stanley cuts to equal-weight from overweight |
* J B Hunt Transport Services Inc JBHT.O: Baird raises target price to $290 from $275 |
* Janus Living JAN.N: Raymond James initiates coverage with strong buy rating; PT $34 |
* Kimberly-Clark KMB.O: Piper Sandler raises target price to $121 from $115 |
* Kla Corp KLAC.O: Citigroup raises target price to $290 from $206.40 |
* Lam Research LRCX.O: Citigroup raises target price to $450 from $315 |
* Landstar System Inc LSTR.O: Baird raises target price to $225 from $195 |
* Leidos Holdings LDOS.N: BofA Global Research cuts PO to $125.00 from $200.00 |
* Leidos Holdings LDOS.N: BofA Global Research cuts to neutral from buy rating |
* Lineage Inc LINE.O: Truist Securities raises target price to $46 from $44 |
* Matson Inc MATX.N: Stephens raises target price to $230 from $217 |
* Micron Technology Inc MU.O: Citigroup raises target price to $1200 from $840 |
* Micron Technology Inc MU.O: Deutsche Bank raises target price to $1,500 from $1,000 |
* Middleby Corp MIDD.O: Oppenheimer initiates coverage With Outperform rating; PT $205 |
* Neovolta Inc NEOV.O: Needham initiates coverage with buy rating; target price $8 |
* Netflix Inc NFLX.O: Moffettnathanson cuts target price by $5 to $115 |
* Omega Healthcare Investors OHI.N: Raymond James resumes coverage with outperform rating |
* Omega Healthcare Investors OHI.N: Raymond James resumes coverage with PT $50 |
* Oncology Institute Inc TOI.O: Needham raises target price to $7 from $5 |
* Paychex Inc PAYX.O: Stifel raises target price to $110 from $105 |
* Permian Resources Corp PR.N: Raymond James cuts target price to $26 from $29 |
* ResMed Inc RMD.N: Morgan Stanley cuts target price to $230 from $286 |
* ResMed Inc RMD.N: Morgan Stanley cuts to equal weight from overweight |
* Robinhood Markets HOOD.O: Deutsche Bank raises target price to $105 from $98 |
* Robinhood Markets Inc HOOD.O: Argus Research raises target price to $110 from $90 |
* Ryder System Inc R.N: Baird raises target price to $290 from $253 |
* Sabra Health Care REIT SBRA.O: Raymond James resumes coverage with underperform rating |
* Schneider National Inc SNDR.N: Baird raises target price to $39 from $35 |
* Tanger Inc SKT.N: Deutsche Bank raises target price to $40 from $35 |
* Tyra Biosciences Inc TYRA.O: Jonestrading initiates coverage with buy rating; PT $56 |
* UnitedHealth UNH.N: Leerink Partners raises target price to $462 from $400 |
* Uniqure NV QURE.O: Van Lanschot Kempen raises target price to $60 from $27 |
* Valmont Industries Inc VMI.N: JP Morgan raises target price to $600 from $520 |
* Valmont Industries Inc VMI.N: Stifel raises target price to $645 from $541 |
* Ventas Inc VTR.N: Raymond James resumes coverage with outperform rating; PT $94 |
* Welltower Inc WELL.N: Raymond James resumes coverage with outperform rating; PT $226 |
* Western Midstream Partners WES.N: Mizuho resumes coverage with outperform rating; PT $48 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Janus Living
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
Brief: Janus Living Announces Pricing Of Public Offering Of Class A-1 Common Stock
Refile: BUZZ-Janus Living dips after launching 25 million share sale
National Healthcare Properties shares fall in Nasdaq debut after REIT's $462-million IPO (updated)
National Healthcare Properties on track for muted debut after $462 million IPO